Indigo Diabetes Funding: $52M Raised, Series B (2020)
Indigo Diabetes is based in Zwijnaarde, Belgium. It has raised $52M in total funding. Latest round: Series B.
Indigo Diabetes funding overview
Indigo Diabetes is based in Zwijnaarde, Belgium. Indigo Diabetes has raised $52M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2020. The round record for Indigo Diabetes runs through 2020; nothing later has been disclosed. Investors on record include Fund+, Ackermans & van Haaren, Capricorn Digital Growth Fund, imec.xpand, Titan Baratto, Powergraph and 7 others. 13 distinct backers are named across the disclosed rounds.
Indigo Diabetes at a glance
Total raised
$52M
Latest round
Series B
Latest round date
January 2020
Headquarters
Zwijnaarde, Belgium
Notable investors
Fund+, Ackermans & van Haaren, Capricorn Digital Growth Fund, imec.xpand, Titan Baratto, Powergraph, Qbic Arkiv Fund, Fidimec
Frequently asked about Indigo Diabetes funding
How much has Indigo Diabetes raised?
Indigo Diabetes has raised $52M in total disclosed funding across the rounds on record.
Who has invested in Indigo Diabetes?
Fund+, Ackermans & van Haaren, Capricorn Digital Growth Fund, imec.xpand, Titan Baratto, Powergraph are named among the investors backing Indigo Diabetes.
What was the latest Indigo Diabetes funding round?
The most recent disclosed round is a Series B, announced in January 2020.
Where is Indigo Diabetes based?
Indigo Diabetes is based in Zwijnaarde, Belgium.
When did Indigo Diabetes last raise?
The last disclosed Indigo Diabetes round closed in January 2020 at Series B.
Every Indigo Diabetes figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Zwijnaarde at a similar stage.
